Not settled. Spyre Therapeutics (SYRE) could not be confirmed either way under the AAOIFI Shari’ah Standard 21 screen.
Yes. Spyre Therapeutics (SYRE) passes the Catholic screen based on the USCCB investment guidelines.
Yes. Spyre Therapeutics (SYRE) passes the Biblically Responsible Investing (BRI) screen.